The Goods and Services Tax Council after its 50th meet in New Delhi on Tuesday has agreed to exempt GST on import of cancer drug Dinutuximab, and Food for Special Medical Purposes (FSMP) used in the treatment of rare diseases. Currently, the drug attracts a 12% integrated GST.
Recent Posts
- Nat Cat claims pull GIC Re’s net profit down 14% to Rs 2456 cr in Q2FY27, Prm rises 17% to Rs 11,228 crore
- New India focuses on underwriting, technology for profitable growth: CMD
- Govt sets up high-level banking reform panel headed by former CVC Suresh N Patel
- AU Small Finance Bank probes potential data leak
- Uttarakhand Chopper crash: All 6 on board have died,insured with New India Assurance
Categories
- Articles
- Banking & Bancassurance
- Blog
- Breaking News!
- Briefs
- Climate, Environment, Renewable Energy
- Data
- Disaster & Management
- Eco/Invest/Demography
- Editorial
- Events
- Facts
- Features
- Health
- Indian News
- Intermediaries
- International News
- Interviews
- Life
- Main Menu
- Non-Life
- Pandemic
- Pension & Social Security
- Policy
- Regulation
- Reinsurance
- Risk Management
- Simple
- Technology
- Trends, Facts
- Uncategorized
- Wealth Management/ Philanthropy
- Workplace/Employee Benefits